Changes in the Characteristics of Patients Prescribed Selective Cyclooxygenase 2 Inhibitors After the 2004 Withdrawal of Rofecoxib

E. Setakis, H.G.M. Leufkens, T.P. van Staa

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1105-1111
Number of pages7
JournalArthritis and Rheumatism
Volume59
Issue number8
Publication statusPublished - 2008

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this